Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
210 | 51916 | 34.4 | 63% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
210 | 3 | IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS | 51916 |
328 | 2 | NK CELLS//NATURAL KILLER CELLS//KIR | 18140 |
1202 | 2 | JOURNAL OF INTERFERON RESEARCH//INTERFERON//JOURNAL OF INTERFERON AND CYTOKINE RESEARCH | 9220 |
1364 | 2 | JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY//MURAMYL DIPEPTIDE//IMMUNOLOGY | 8243 |
2020 | 2 | CELLULAR IMMUNOLOGY//IMMUNOLOGY//EPICUTANEOUS IMMUNIZATION | 5452 |
2729 | 2 | THYMOSIN BETA 4//THYMOSIN ALPHA 1//PROTHYMOSIN ALPHA | 3281 |
3041 | 2 | PSK//OK 432//IMEXON | 2463 |
3092 | 2 | POSTOPERATIVE SEPTIC COMPLICATIONS//TREATMENT RELATED TOXICITIES//MIGRATION STIMULATION FACTOR | 2357 |
3238 | 2 | ARBIDOL//VOPROSY VIRUSOLOGII//COOPERAT MED | 2003 |
3950 | 2 | KURLOFF CELL//ALPHA NAPHTHYL ACETATE ESTERASE//ANAE | 757 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | IMMUNOLOGY | WoSSC | 416345 | 43% | 3% | 22364 |
2 | JOURNAL OF INTERFERON RESEARCH | journal | 208474 | 1% | 61% | 588 |
3 | NK CELLS | authKW | 203517 | 2% | 32% | 1088 |
4 | NATURAL KILLER CELLS | authKW | 189589 | 2% | 30% | 1073 |
5 | CELLULAR IMMUNOLOGY | journal | 156733 | 3% | 19% | 1451 |
6 | JOURNAL OF IMMUNOLOGY | journal | 128290 | 7% | 7% | 3470 |
7 | INTERLEUKIN 2 | authKW | 119781 | 2% | 24% | 848 |
8 | KIR | authKW | 116815 | 1% | 73% | 275 |
9 | NKG2D | authKW | 107565 | 1% | 69% | 266 |
10 | CANCER IMMUNOLOGY IMMUNOTHERAPY | journal | 94423 | 2% | 19% | 841 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 416345 | 43% | 3% | 22364 |
2 | Oncology | 44384 | 17% | 1% | 8717 |
3 | Medicine, Research & Experimental | 16090 | 8% | 1% | 3978 |
4 | Cell Biology | 14965 | 11% | 1% | 5489 |
5 | Hematology | 8488 | 5% | 1% | 2440 |
6 | Virology | 4953 | 3% | 1% | 1491 |
7 | Biochemistry & Molecular Biology | 4564 | 12% | 0% | 6477 |
8 | Transplantation | 3763 | 2% | 1% | 1127 |
9 | Pathology | 3506 | 3% | 1% | 1575 |
10 | Pharmacology & Pharmacy | 1644 | 6% | 0% | 3161 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ECCELLENZA RIC BIOMED | 30673 | 0% | 55% | 95 |
2 | CANC IMMUNOL PROGRAM | 14826 | 0% | 23% | 113 |
3 | IMMUNOL | 12967 | 3% | 2% | 1443 |
4 | DIPARTIMENTO MED SPERIMENTALE | 10198 | 0% | 10% | 172 |
5 | SECT BIOMED CHEM | 10189 | 0% | 87% | 20 |
6 | SEZ ISTOL | 8762 | 0% | 44% | 34 |
7 | NO IRELAND REG HISTOCOMPATIBIL IMMUNOGENET | 7630 | 0% | 47% | 28 |
8 | EXPT IMMUNOL | 6629 | 0% | 6% | 187 |
9 | LAUTENBERG GEN TUMOR IMMUNOL | 6314 | 0% | 17% | 64 |
10 | CANC CELL DEATH | 6242 | 0% | 67% | 16 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF INTERFERON RESEARCH | 208474 | 1% | 61% | 588 |
2 | CELLULAR IMMUNOLOGY | 156733 | 3% | 19% | 1451 |
3 | JOURNAL OF IMMUNOLOGY | 128290 | 7% | 7% | 3470 |
4 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 94423 | 2% | 19% | 841 |
5 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 65103 | 0% | 48% | 233 |
6 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 63833 | 1% | 23% | 472 |
7 | JOURNAL OF INTERFERON AND CYTOKINE RESEARCH | 33628 | 1% | 16% | 362 |
8 | EUROPEAN JOURNAL OF IMMUNOLOGY | 32995 | 2% | 7% | 877 |
9 | IMMUNOLOGY | 30793 | 1% | 8% | 690 |
10 | JOURNAL OF EXPERIMENTAL MEDICINE | 29614 | 2% | 7% | 803 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NK CELLS | 203517 | 2% | 32% | 1088 | Search NK+CELLS | Search NK+CELLS |
2 | NATURAL KILLER CELLS | 189589 | 2% | 30% | 1073 | Search NATURAL+KILLER+CELLS | Search NATURAL+KILLER+CELLS |
3 | INTERLEUKIN 2 | 119781 | 2% | 24% | 848 | Search INTERLEUKIN+2 | Search INTERLEUKIN+2 |
4 | KIR | 116815 | 1% | 73% | 275 | Search KIR | Search KIR |
5 | NKG2D | 107565 | 1% | 69% | 266 | Search NKG2D | Search NKG2D |
6 | THYMOSIN BETA 4 | 90971 | 0% | 82% | 189 | Search THYMOSIN+BETA+4 | Search THYMOSIN+BETA+4 |
7 | INTERLEUKIN 15 | 65866 | 0% | 57% | 198 | Search INTERLEUKIN+15 | Search INTERLEUKIN+15 |
8 | IL 15 | 64423 | 0% | 49% | 225 | Search IL+15 | Search IL+15 |
9 | KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR | 60384 | 0% | 82% | 126 | Search KILLER+CELL+IMMUNOGLOBULIN+LIKE+RECEPTOR | Search KILLER+CELL+IMMUNOGLOBULIN+LIKE+RECEPTOR |
10 | THYMOSIN ALPHA 1 | 55789 | 0% | 76% | 125 | Search THYMOSIN+ALPHA+1 | Search THYMOSIN+ALPHA+1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TRINCHIERI, G , (1989) BIOLOGY OF NATURAL-KILLER CELLS.ADVANCES IN IMMUNOLOGY. VOL. 47. ISSUE . P. 187 -376 | 580 | 62% | 2514 |
2 | LANIER, LL , (2005) NK CELL RECOGNITION.ANNUAL REVIEW OF IMMUNOLOGY. VOL. 23. ISSUE . P. 225 -274 | 236 | 69% | 1482 |
3 | PESTKA, S , LANGER, JA , ZOON, KC , SAMUEL, CE , (1987) INTERFERONS AND THEIR ACTIONS.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 56. ISSUE . P. 727-777 | 312 | 78% | 1517 |
4 | CARAPITO, R , BAHRAM, S , (2015) GENETICS, GENOMICS, AND EVOLUTIONARY BIOLOGY OF NKG2D LIGANDS.IMMUNOLOGICAL REVIEWS. VOL. 267. ISSUE 1. P. 88 -116 | 213 | 83% | 12 |
5 | PLAYER, MR , TORRENCE, PF , (1998) THE 2-5A SYSTEM: MODULATION OF VIRAL AND CELLULAR PROCESSES THROUGH ACCELERATION OF RNA DEGRADATION.PHARMACOLOGY & THERAPEUTICS. VOL. 78. ISSUE 2. P. 55 -113 | 320 | 77% | 201 |
6 | PAHL, J , CERWENKA, A , (2017) TRICKING THE BALANCE: NK CELLS IN ANTI-CANCER IMMUNITY.IMMUNOBIOLOGY. VOL. 222. ISSUE 1. P. 11 -20 | 98 | 62% | 5 |
7 | WHITTINGTON, R , FAULDS, D , (1993) INTERLEUKIN-2 - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN PATIENTS WITH CANCER.DRUGS. VOL. 46. ISSUE 3. P. 446-514 | 335 | 73% | 183 |
8 | CHOWDHURY, D , LIEBERMAN, J , (2008) DEATH BY A THOUSAND CUTS: GRANZYME PATHWAYS OF PROGRAMMED CELL DEATH.ANNUAL REVIEW OF IMMUNOLOGY. VOL. 26. ISSUE . P. 389-420 | 161 | 80% | 200 |
9 | CHAMPSAUR, M , LANIER, LL , (2010) EFFECT OF NKG2D LIGAND EXPRESSION ON HOST IMMUNE RESPONSES.IMMUNOLOGICAL REVIEWS. VOL. 235. ISSUE . P. 267-285 | 121 | 86% | 233 |
10 | LANIER, LL , (1998) NK CELL RECEPTORS.ANNUAL REVIEW OF IMMUNOLOGY. VOL. 16. ISSUE . P. 359 -393 | 166 | 62% | 1231 |
Classes with closest relation at Level 3 |